These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7086136)

  • 61. In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.
    Yardley V; Khan AA; Martin MB; Slifer TR; Araujo FG; Moreno SN; Docampo R; Croft SL; Oldfield E
    Antimicrob Agents Chemother; 2002 Mar; 46(3):929-31. PubMed ID: 11850291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
    Morimoto A; Omachi S; Osada Y; Chambers JK; Uchida K; Sanjoba C; Matsumoto Y; Goto Y
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004505. PubMed ID: 26942577
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Investigation of non-specific immune suppression in DBA/1 mouse infected by L. donovani].
    Yi TL; Hu XS; Feng RY
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Mar; 17(1):13-6. PubMed ID: 3804302
    [No Abstract]   [Full Text] [Related]  

  • 64. Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis.
    Yurdakul P; Dalton J; Beattie L; Brown N; Erguven S; Maroof A; Kaye PM
    Am J Pathol; 2011 Jul; 179(1):23-9. PubMed ID: 21703391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of Leishmania donovani promastigotes with human phagocytes.
    Pearson RD; Sullivan JA; Roberts D; Romito R; Mandell GL
    Infect Immun; 1983 Apr; 40(1):411-6. PubMed ID: 6832834
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of Leishmania populations within the host. V. Resistance to L.donovani in wild mice.
    Blackwell JM
    J Trop Med Hyg; 1983 Feb; 86(1):17-22. PubMed ID: 6854699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages.
    Kirby AC; Beattie L; Maroof A; van Rooijen N; Kaye PM
    Am J Pathol; 2009 Sep; 175(3):1107-15. PubMed ID: 19644016
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Immunologic phenomena in experimental toxoplasmosis. I. In vitro study in Balb-C mice].
    Floc'h F; Vernes A; Biguet J
    Ann Parasitol Hum Comp; 1972; 47(5):667-79. PubMed ID: 4661613
    [No Abstract]   [Full Text] [Related]  

  • 69. Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster.
    Farrell JP
    Exp Parasitol; 1976 Aug; 40(1):89-94. PubMed ID: 950004
    [No Abstract]   [Full Text] [Related]  

  • 70. Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.
    Nieto A; Domínguez-Bernal G; Orden JA; De La Fuente R; Madrid-Elena N; Carrión J
    Vet Res; 2011 Feb; 42(1):39. PubMed ID: 21345200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of macrophages by lymphokines from specifically sensitized lymphocytes with Yersinia pseudotuberculosis.
    Neychev H; Slavcheva E
    Acta Microbiol Bulg; 1988; 22():22-7. PubMed ID: 3247857
    [No Abstract]   [Full Text] [Related]  

  • 72. Pathogenesis of anaemia in hamsters infected with Leishmania donovani.
    Agu WE; Farrell JP; Soulsby EJ
    Z Parasitenkd; 1982; 68(1):27-32. PubMed ID: 7136193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates.
    Murray HW
    J Exp Med; 1981 Jun; 153(6):1690-5. PubMed ID: 7252424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients.
    Kumar P; Pai K; Pandey HP; Sundar S
    J Med Microbiol; 2002 Oct; 51(10):832-836. PubMed ID: 12435061
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Macrophage heterogeneity, antigen presentation, and membrane fluidity: implications in visceral Leishmaniasis.
    Sen E; Chattopadhyay S; Bandopadhyay S; De T; Roy S
    Scand J Immunol; 2001 Feb; 53(2):111-20. PubMed ID: 11169214
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of cortisone and cyclophosphamide on the immunological role of BCG in Balb/c mice challenged with Leishmania donovani.
    Smrkovski LL; Reed SG; Larson CL
    Am J Trop Med Hyg; 1980 Jan; 29(1):16-20. PubMed ID: 7352623
    [No Abstract]   [Full Text] [Related]  

  • 77. Elimination of Leishmania donovani amastigotes by activated macrophages.
    Haidaris CG; Bonventre PF
    Infect Immun; 1981 Sep; 33(3):918-26. PubMed ID: 7287190
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The potential role of Leishmania antigens and immunoglobulins in the pathogenesis of glomerular lesions of hamsters infected with Leishmania donovani.
    Oliveira AV; Rossi MA; Rogue-Barreira MC; Sartori A; Campos-Neto A
    Ann Trop Med Parasitol; 1985 Oct; 79(5):539-43. PubMed ID: 3909974
    [No Abstract]   [Full Text] [Related]  

  • 79. Leishmania donovani: action of excreted factor on hydrolytic enzyme activity of macrophages from mice with genetically different resistance to infection.
    El-On J; Bradley DJ; Freeman JC
    Exp Parasitol; 1980 Apr; 49(2):167-74. PubMed ID: 6767620
    [No Abstract]   [Full Text] [Related]  

  • 80. Functional analysis of the murine T lymphocyte immune response to a protozoan parasite, Leishmania tropica.
    Engers HD; Coutinho SG; de Araújo Lima GM; Louis JA
    Mem Inst Oswaldo Cruz; 1983; 78(1):105-20. PubMed ID: 6606105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.